iPill is a California medtech company building a patented smart dispenser and companion app that secure controlled substances at home: medication is released only to the prescribed patient after two-point biometric authentication, doses are capped at the prescription, a biosensor monitors respiration, and unused pills are destroyed on tampering or prescription expiry. Founded by board-certified anesthesiologist Dr. John Hsu, the company runs a B2B hardware-plus-SaaS model for opioid treatment programs, behavioral health centers, justice systems and chronic-pain providers, and holds an FDA Breakthrough Device designation. It is onboarding pilot program providers from November 2026.
1
Round
1
Industry
4
Tags
Oct 13, 2026
Latest raise
Funding activity · 1 round
Oct 13, 2026
$1.3M
Seed
Article coming soon.
Pricing
Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.
For individuals and small teams getting started with AI buyer intelligence.
$149
/month
Features
For outbound teams and agencies that need more coverage and faster signal cadence.
$249
/month
Features
Act on this raise
Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.
